Introduction
Psoriasis is a chronic immune-mediated inflammatory skin disorder characterized by epidermal hyperproliferation, abnormal keratinocyte differentiation, and persistent immune activation involving the IL-23/Th17 axis, Th1 polarization, and NF-κB–mediated inflammatory signaling. The disease is driven by dysregulated cytokine networks including TNF-α, IL-17, IL-23, and IFN-γ, which collectively sustain cutaneous inflammation, angiogenesis, and barrier dysfunction.
In recent years, Guduchi (Tinospora cordifolia) has gained significant scientific interest due to its immunomodulatory and immune homeostasis–restoring properties.1 Contemporary pharmacological studies suggest its role in balancing Th1/Th17 responses and regulating inflammatory cytokine production, making it a promising adjunct phytotherapeutic agent in psoriasis management.
Phytochemical profile of Tinospora cordifolia
Tinospora cordifolia contains a wide spectrum of bioactive constituents responsible for its immunomodulatory and anti-inflammatory effects.
Major bioactive constituents include:
- Diterpenoid lactones: tinosporide, cordifolide, columbin
- Alkaloids: magnoflorine, berberine
- Glycosides and polysaccharides
- Steroids and phenolic compounds
- Immunologically active arabinogalactan polysaccharides
Among these, polysaccharide fractions are considered key mediators of immune modulation through macrophage activation and cytokine regulation.
Pathophysiology of psoriasis relevant to immune modulation
- Th1/Th17 axis dysregulation:
Psoriasis is strongly associated with increased Th1 and Th17 immune responses, leading to elevated IFN-γ, TNF-α, IL-17, and IL-23, which drive keratinocyte proliferation and sustained inflammation.
- NF-κB–mediated inflammatory amplification:
Activation of NF-κB signaling promotes transcription of pro-inflammatory cytokines, maintaining chronic cutaneous immune activation.
- Innate immune activation:
Dendritic cell hyperactivation enhances antigen presentation and cytokine release, further promoting adaptive immune dysregulation.
- Oxidative stress and inflammatory feedback loop:
Reactive oxygen species amplify cytokine signaling and worsen epidermal injury and barrier dysfunction.
Mechanisms of therapeutic action of Guduchi in psoriasis
- Immune homeostasis restoration:
Tinospora cordifolia exhibits bidirectional immunomodulatory activity, normalizing overactive immune responses while enhancing impaired immune functions. This helps restore immune equilibrium in psoriatic inflammation.
- Th1/Th17 modulation:
Guduchi downregulates Th17-associated cytokines (IL-17, IL-23) and modulates Th1 responses (IFN-γ, TNF-α), thereby reducing keratinocyte hyperproliferation and inflammatory plaque development.
- NF-κB pathway inhibition:
Bioactive constituents suppress NF-κB activation, leading to decreased transcription of pro-inflammatory mediators and attenuation of chronic skin inflammation.
- Macrophage and dendritic cell regulation:
Tinospora cordifolia modulates innate immune cell activity, reducing excessive antigen presentation and inflammatory cytokine release, thereby limiting autoimmune amplification.
- Antioxidant and cytoprotective effects:
Guduchi enhances endogenous antioxidant enzyme activity and scavenges reactive oxygen species, reducing oxidative damage to keratinocytes and improving epidermal integrity.
- Anti-inflammatory cytokine balance (therapeutic role):
It reduces levels of TNF-α, IL-6, and IL-1β while promoting regulatory cytokine balance, contributing to controlled inflammatory responses in psoriatic lesions.
Experimental and preclinical evidence
Preclinical studies on Tinospora cordifolia demonstrate:
- Suppression of pro-inflammatory cytokines in immune activation models
- Downregulation of Th1/Th17-associated signaling pathways
- Reduction in oxidative stress markers and enhancement of antioxidant defenses
- Improved macrophage-mediated immune regulation
- Attenuation of NF-κB–dependent inflammatory responses
These findings support its multi-level immunomodulatory activity relevant to psoriasis pathogenesis.
Therapeutic role in psoriasis management
- Immunomodulatory adjunct therapy:
Guduchi helps restore immune balance, making it useful in immune-driven inflammatory skin disorders such as psoriasis.2
- Th1/Th17 axis regulator:
It reduces pathogenic T-cell signaling, thereby decreasing plaque formation and disease severity.
- Anti-inflammatory phytotherapeutic agent:
Reduces cytokine-mediated inflammation and supports reduction of erythema and scaling.
- Oxidative stress modulator:
Protects epidermal cells from oxidative injury and supports barrier repair mechanisms.
Integrative dermatological support:
May serve as an adjunct to conventional therapies such as topical corticosteroids and systemic immunomodulators.
Clinical relevance and limitations
Despite strong preclinical evidence, clinical validation remains limited. Key limitations include:
- Lack of large-scale randomized controlled trials in psoriasis
- Variability in extract standardization and phytochemical composition
- Limited pharmacokinetic and dose-response data
- Need for standardized immunological biomarkers in clinical studies
Thus, Guduchi should currently be considered a supportive immunomodulatory agent rather than a standalone therapy in psoriasis management.3
Conclusion
Tinospora cordifolia (Guduchi) demonstrates significant therapeutic potential in psoriasis through immune homeostasis restoration and modulation of the Th1/Th17 axis. Its multi-target actions—including NF-κB inhibition, cytokine regulation, macrophage modulation, and antioxidant activity—highlight its relevance in immune-mediated inflammatory skin disease. However, further well-designed clinical trials are required to establish standardized therapeutic protocols and confirm its efficacy and safety in psoriasis management.
References:
- Singh J, Saxena E, Chaudhary AR, et al. Immunomodulatory properties of Giloy (Tinospora cordifolia) leaves and its applications in value-added products. Heliyon. 2024;11(1):e40948. Published 2024 Dec 7. doi:10.1016/j.heliyon.2024.e40948. https://pmc.ncbi.nlm.nih.gov/articles/PMC11699423/
- Gupta A, Gupta P, Bajpai G. Tinospora cordifolia (Giloy): An insight on the multifarious pharmacological paradigms of a most promising medicinal ayurvedic herb. Heliyon. 2024;10(4):e26125. Published 2024 Feb 15. doi:10.1016/j.heliyon.2024.e26125. https://pmc.ncbi.nlm.nih.gov/articles/PMC10882059/
- Choudhury B, Pal R. A systematic review of the immunomodulatory effects and therapeutic applications of Withania somnifera, Tinospora cordifolia, Cinnamomum zeylanicum, and Piper longum: underlying mechanisms and clinical significance. Journal of Natural Remedies. 2025. DOI: 10.18311/jnr/2025/48101. DOI: 10.18311/jnr/2025/48101